Baltimore startup raises $3.5M as it prepares to seek FDA approval for new pneumonia test


The antigen test created by Pearl Diagnostics, led by a Johns Hopkins University professor, has already been approved for use in Europe.

Previous Matchwell employees score payout as Durham startup acquired
Next All the details behind Meridian Bioscience's pending $1.53B acquisition